AMA #9: Kratom Risks, Does Infrared Sauna Work & Journaling Benefits
Watch on YouTubeVideo summary
In this Ask Me Anything episode, Dr. Andrew Huberman addresses questions regarding kratom, infrared saunas, and journaling benefits, focusing primarily on the neurobiological risks associated with kratom usage. Kratom (*Mitragyna speciosa*), a tree native to Indonesia whose leaves have been chewed for centuries, contains alkaloids that act as opioids in the human body. While low dosages may produce mild stimulant effects or euphoria, higher doses trigger analgesic and sedative properties by binding preferentially to mu opioid receptors, similar to prescription drugs like morphine and hydrocodone. Huberman clarifies a common misconception among proponents who claim kratom is distinct because it binds more to kappa receptors; in reality, its primary mechanism involves the same mu receptor system responsible for pain relief and reinforcement circuitry involving dopamine and serotonin. Consequently, kratom possesses significant habit-forming potential and can lead to addiction, particularly when dosages are increased over time or when individuals possess a genetic predisposition to respond potently to opioids. The discussion highlights a critical distinction between being "habit-forming" and clinically "addicted," defining the latter as continuing use despite negative consequences or experiencing withdrawal symptoms upon cessation. Huberman notes that while some users successfully wean off potent prescription opioids using kratom, this practice carries substantial risks because individuals often ratchet up their dosage to match previous opioid effects, effectively swapping one addiction for another. He emphasizes that approximately 10% to 40% of the population responds to substances like alcohol and opioids with an exaggerated dopamine release, making them highly susceptible to use disorders; these specific subgroups should strictly avoid kratom entirely. Furthermore, unlike some other supplements, opioid-based products lack rigorous regulation in the United States, meaning that even identical gram measurements from different brands can contain wildly varying concentrations of active alkaloids, leading to unpredictable physiological responses and increased risks of respiratory depression, especially when combined with alcohol or other depressants. Huberman also addresses safety concerns regarding death by kratom, noting that while rare at recommended dosages on commercial packaging, fatalities have occurred, often linked to the suppression of respiration similar to traditional opioids but exacerbated by mixing substances. He explains the physiological mechanism behind opioid-induced respiratory failure involving the "physiological sigh," a breathing pattern discovered in the 1930s and studied further by Dr. Jack Feldman at UCLA that helps reinflate lungs during sleep; opioids bind to brainstem receptors that generate these sighs, suppressing them and leading to fatal lack of oxygenation if combined with other depressants or taken in high doses. The overarching conclusion for those who have never tried kratom is a strong recommendation to avoid it completely due to the impossibility of predicting one's individual genetic response without risking addiction. For current users, he advises careful monitoring of dosage and an ultimate goal of tapering off all opioid-like substances rather than maintaining long-term dependence on kratom as a substitute for other drugs or pain management strategies. The episode concludes with Huberman reiterating the importance of supporting scientific research into mental health, physical health, and performance through his premium channel, which funds human-based studies at Stanford and is matched dollar-for-dollar by The Tiny Foundation. He encourages listeners to prioritize behavioral interventions before nutrition or supplementation, noting that while he supports many supplements under certain conditions, opioid compounds require extreme caution due to their high abuse potential. Huberman maintains a balanced view on substances like cannabis and alcohol, acknowledging therapeutic applications for some while warning against use in vulnerable populations, such as young males with psychosis risks regarding THC. Ultimately, the message is one of evidence-based prudence: understanding that kratom acts biologically similar to powerful prescription opioids means it should not be viewed as benign or safe without significant reservations, and individuals must make informed decisions based on their unique neurochemistry rather than anecdotal testimonials from either pro-kratom or anti-kratom camps.
Read the full video transcript
Welcome to the Huberman Lab podcast,
where we discuss science and
science-based tools for everyday life.
I'm Andrew Huberman and I'm a professor
of neurobiology and ophthalmology at
Stanford School of Medicine. Today is an
Ask Me Anything episode or AMA. This is
part of our premium subscriber channel.
Our premium subscriber channel was
started in order to provide support for
the standard Huberman Lab podcast, which
comes out every Monday and is available
at zero cost to everybody on all
standard feeds, YouTube, Apple, Spotify,
and elsewhere. We also started the
premium channel as a way to generate
support for exciting research being done
at Stanford and elsewhere. Research on
human beings that leads to important
discoveries that assist mental health,
physical health, and performance. I'm
also pleased to inform you that for
every dollar the Huberman Lab premium
channel generates for research studies,
the Tiny Foundation has agreed to match
that amount. So, now we are able to
double the total amount of funding given
to studies of mental health, physical
health, and human performance. If you'd
like to subscribe to the Huberman Lab
podcast premium channel, please go to
hubermanlab.com/premium.
It is $10 a month to subscribe or you
can pay $100 all at once to get an
entire 12-month subscription for a year.
We also have a lifetime subscription
model that is a one-time payment and
again, you can find that option at
hubermanlab.com/premium.
For those of you that are already
subscribers to the premium channel,
please go to hubermanlab.com/premium
and download the premium subscription
feed. And for those of you that are not
Huberman Lab podcast premium
subscribers, you can still hear the
first 20 minutes of today's episode and
determine whether or not becoming a
premium subscriber is for you. So,
without further ado, let's get to
answering your questions. The first
question is about kratom and the
question is, what are the short and
long-term effects of taking kratom? For
those of you that haven't heard of
kratom, kratom is a substance that comes
from a tree that grows naturally in
Indonesia. The tree itself is called
Mitragyna Speciosa and it's been known
for hundreds of years or more. We don't
really know how long, but at least for a
couple of hundred years
that when people chew the leaves of this
tree, they experience a mild stimulant
effect. And there's also a process of
extraction whereby you can take the
leaves and get high concentrations of
kratom that nowadays is packaged into
various supplements. Most often consumed
in capsule form, although sometimes it's
sold in raw powder form.
Here's the key thing to understand about
kratom. Indeed, at low dosages, kratom
has a mild stimulant effect. However, at
higher dosages
it has what's called an analgesic
effect, that is a painkilling effect,
and it acts as a sedative.
And kratom itself acts as an opioid in
the body. This is what's making kratom a
very controversial topic these days.
In particular, because most people have
heard of the so-called opioid crisis.
The opioid crisis has been a term coined
to largely center around issues that
have taken place in the United States,
although these issues definitely extend
beyond the borders of the United States.
But the opioid crisis is essentially the
overconsumption and widespread addiction
to opioids. Opioids include things like
morphine
oxycodone, also called OxyContin, and
there are other opioids similar to those
compounds, all of which have the general
effect of being painkillers and
sedatives. And in some people, again,
some people
eliciting a sense of euphoria, in
particular at low to moderate dosages.
However, people quickly develop a
tolerance to those drugs and need to
consume more and more of them in order
to get the effect that they initially
got from a lower dosage. And they are
not just highly habit-forming, they are
highly addictive. And we can distinguish
between habit-forming and addictive by
simply saying that addictive means
people will continue to take something
or do something despite negative
consequences. There are other relevant
definitions of addiction as well. I
define addiction more broadly as the
progressive narrowing of the things that
give you pleasure. And indeed, when
people get addicted to opioids, it is a
very bad picture.
It often hampers many, many areas of
their lives and seriously so.
So, the opioid crisis refers to the
over-prescription of opioid drugs.
That's sort of what it's generally taken
to mean, but it also includes accessing
opioids such as morphine, oxycodone,
etc. through gray market sources,
through black market sources, and on and
on.
And of course,
the acquisition of the drugs is just one
piece. It's also the over-consumption of
those drugs and of course, the addiction
to those drugs, which has proved to be
so pernicious.
So, what does this have to do with
kratom? Kratom is also an opioid and
we'll talk about how it differs
in its opioid properties from the drugs
I just talked about because it is
different from morphine and hydrocodone,
but it also has some similar properties
as well.
But, the deal with kratom is that a good
number of people out there have managed
to wean themselves off opioids such as
morphine and hydrocodone through the use
of kratom. And that has been used as a
justification for keeping kratom on the
market and keeping it legal. However,
and this is a very important however,
kratom itself has also proved to be not
only habit-forming, but addictive,
especially when taken at dosages that
exceed that lower dose that just
generally creates a bit of stimulant, a
little bit of euphoric effect. When
people start taking higher dosages of
kratom, it is very clear that it does
become addictive and itself is very hard
to come off of. So much so that people
experience so-called kratom withdrawal.
Now, the reason I mentioned that kratom
has been used by a good number of people
to wean themselves off of the more
potent forms of prescription opioids
is that when I solicited for questions
about kratom on social media, it was a
very binary response. In fact, there was
one camp, a very rapid camp, that said,
"Kratom is terrible. I took this stuff.
I got addicted. It was extremely hard to
come off of."
There were additional comments in there
such as I know somebody who literally
had to go to rehab because of kratom,
who developed a bunch of other
addictions because of kratom.
Essentially, many, many responses of
people who had only bad experiences with
kratom, meaning they liked it enough at
first that they continued to take it and
it became addictive for them or somebody
that they know. However, there was
another camp that was equally vocal,
which kept saying, "No, if one really
adheres to the lower dosages of kratom,
kratom itself can be a useful tool for
getting off other opioids." And there
were even a few bonafide medical
professionals, medical doctors that is,
and I happen to know them and their
reputations are quite good, who chimed
in and sort of reconciled the two camps
by saying, "Indeed, if one can avoid
taking kratom at all,
you should. There is no reason to take
this thing thinking that it's, quote
unquote, good for you. You would be wise
to avoid taking it because there is a
high probability, if you take it at a
given dosage or at a dosage that is
going to get your brain and body into a
state of
euphoria and analgesia and that sort of
classic opioid effect, that it's going
to become habit-forming or addicting for
you."
That said, these same medical
professionals acknowledged that a fair
number of people that they knew managed
to get off of the more potent forms of
opioids such as morphine, oxycodone, and
so forth using kratom. And they said,
"Well, if it's a choice between being
addicted to morphine and hydrocodone
versus taking kratom and addicted to
those substances, and kratom somehow
allowed them to taper off of those
substances,
that they would look more favorably upon
kratom if and only if they would also
commit to progressively lowering their
dose of kratom and eventually coming off
of kratom. So, the general takeaway from
all of that is if you can avoid taking
kratom, meaning if you haven't taken it
already, don't. And that reminds me of a
very important point, which a guest on
the Huberman Lab podcast, Dr. Robert
Malenka, who's a MD and PhD, is my
colleague at Stanford School of
Medicine. He's a world expert on the
mechanisms underlying addiction and
dopamine and drug reinforcement among
many other things.
What he said on the podcast is
absolutely true, which is that it is
impossible to get addicted to a
substance that you've never consumed.
That might seem obvious, but think about
that one again. It is impossible to get
addicted to a substance that you've
never consumed. So, I think the safest
statement to make is if you have not
tried kratom, you would be wise to avoid
it because you stand a chance to become
addicted to it. If, however, you are
somebody that's addicted to other forms
of opioids, you absolutely should talk
to your physician about that and how to
get off of those opioids, but there is
evidence that some people have used
kratom to successfully wean themselves
off the more potent forms of opioids
that I talked about, namely morphine and
hydrocodone as well as a few others.
Now, if you're somebody who already
takes kratom, you need to be very
thoughtful about the dosage that you
take. And you also need to be thoughtful
about the fact that people differ
dramatically in their response to
opioids. This is oh so important and
people do not talk about this enough. We
hear, for instance, that oh, you know,
if people are taking anywhere from 1 to
5 g, maybe 1 to 6 g of kratom to per
day, that's keeping it in the dosage
range for which people don't generally
tend to get addicted. You'll hear things
like that. And by the way, when I say 1
to 5 or 1 to 6 g per day, I'm not
talking about the individual compounds
that are present in kratom. There are a
couple of different plant alkaloids I'll
talk about in a moment that are present
in kratom, and these have different
effects on the opioid system. So,
nowadays, some of the companies that
sell kratom, and by the way, this is
sold over the counter as a supplement.
It does not require a prescription to
purchase, at least at this point in time
in the United States. Some of these
products will have a higher
concentration of one or the other
alkaloids within them, such that you
can't really compare 1 g of one brand of
kratom to 1 g of another brand of kratom
because they can have wildly different
levels of these different alkaloids, and
these different alkaloids have wildly
different impact on different aspects of
your brain and body biology. In
particular, how much they tend to impact
the so-called endogenous opioid system.
Okay, so when we talk about dosages, we
have to keep this in the back of our
mind, and we have to keep in the back of
our mind that there does seem to be a
subgroup of people. We don't know how
big this subgroup of people is, but we
know it's not everyone, but it's
somewhere between 10 and 40% of people
seem to respond to opioids in a
particularly potent way. They really
like them. And perhaps not surprisingly,
people outside of that category don't
tend to like opioids. I can certainly
say that I am somebody who, when I've
been prescribed things like Vicodin or
any other opioid post-surgery for pain,
I hate taking those drugs. I absolutely
hate it. I'd rather deal with the pain.
They make me nauseous. They make me feel
terrible. That said, I know people who
love opioids. It's like a natural fit
for their chemistry in the sense that it
tends to evoke more euphoria. They just
immediately like the feeling. Some of
you may remember the episode of the
Huberman Lab Podcast that I did about
alcohol, and there too, I discussed the
fact that about 8 to 10% of people who
consume alcohol get an increased
dopamine response to alcohol that's not
observed in other people. And that
particular subgroup of people is very,
very at risk for developing alcohol use
disorder, sometimes called alcoholism.
Because they can drink in a way and they
experience a high from drinking in a way
that other people simply do not
experience. Now, like everybody else, if
they consume too much alcohol, they get
drunk. So, it's not about the drunk
effect, it's about the dopamine and
other sorts of chemicals that are
released in those people in response to
alcohol that other people just don't
seem to experience at the same level of
potency. So, again with things like
kratom and the other opioids, there's a
category of people and it's a much
larger category of people, again, 10 to
40%. We don't know exactly how many
because the studies are not really
completed and there aren't enough of
those studies yet, unfortunately. But,
when those people take an opioid,
wow, oh wow, do they like it? And those
people in particular are very much at
risk for developing an addiction to
opioids. And so, those people especially
should never, ever go near kratom if
they haven't. Or if they are already
taking kratom, these are the people that
are constantly ratcheting up their dose.
These are the people that tell you, "No,
I'm not addicted, but if you were to
say, 'Hey, all right, well then let's do
an experiment where you don't take
kratom for a week.'" Those are going to
be the people that are suddenly going to
get anxious about the mere idea of that.
I've also talked about this in reference
to cannabis when I did an episode about
cannabis. Again, I'm not putting a
blanket statement out there about
cannabis as being good or bad. On that
episode, I talked about the fact that
cannabis does indeed have various
therapeutic uses, but that there are a
good number of people who rely on
cannabis for anxiety control and other
ways of modulating their brain chemistry
and bodily chemistry such that if you
were to say, "Hey, are you addicted to
cannabis?" They'd say, "No, I don't have
to smoke cannabis. I don't have to take
my edibles." But, if you were to push
them a little bit and say, "All right,
well then, you know, let's do an
experiment where you don't consume any
cannabis in any form for 10 days."
They don't like the idea of that
experiment at all. So much so that were
they to run that experiment, they would
experience a lot of the withdrawal
symptoms associated with addiction. So,
I can't in good faith say that kratom is
safe for everybody because it is simply
not. Now, is it safer than the other
opioids? And if so, why? Well, in order
to address that, let's take a short
glance at the pharmacology of kratom and
how it works in terms of its
neurochemistry in the body. And I'm
going to keep this pretty brief because
in the future I'm going to do an
extended episode all about opioids and I
will include kratom in that
conversation. But, just to back up a
little bit
and discuss what opioids are. Opioids
are compounds that can activate the
so-called endogenous opioid system. All
of us have within our brain and body
the capacity to release our own opioids.
That's right, you have opioids within
your body. They are released from
neurons and they bind to so-called
opioid receptors.
Perhaps some of you have heard of the
so-called runner's high. The runner's
high is a euphoric state. It's a fairly
mild euphoric state in most cases, but
it's a euphoric state induced by long
duration effort.
AKA the runner's high. The runner's high
is just a phrase used to explain that
when we engage in long duration
repetitive action effort,
the body starts releasing these
endogenous opioids. They bind to
receptors and they trigger things like
analgesia, relief from pain. They
trigger mild euphoria. They tend to
change our perception of the outside
world, make things look more beautiful,
shiny. They give things a little bit of
a sheen. What I just described is a mild
version of what people experience when
they take something like morphine. When
people take morphine, there's a more of
a sedative effect. There's more of a
euphoric effect and there's more of a
dream-like effect. And again, it will
depend on dosage. Kratom
and morphine and hydrocodone all have
the property of acting like the
endogenous opioids,
but at much higher potency. When you
bring them into your system, they cross
the blood-brain barrier, so they go into
the brain, and they bind to a number of
different opioid receptors. There's the
mu opioid receptor. By the way, these
names all follow Greek alphabet letters,
so the mu opioid receptor, the kappa
opioid receptor, there are a bunch of
different ones.
Kratom binds preferentially to the mu
opioid receptor and somewhat to the
kappa opioid receptor. There's a big
misconception out there. A lot of
people, especially people who are
proponents of kratom, will say, "No,
morphine and hydrocodone bind the mu
opioid receptor, whereas kratom binds
the kappa opioid receptor, so it's a
different compound, very, very
different." Not true.
Not true.
Kratom, morphine, and hydrocodone all
bind to the mu opioid receptor, and
that's what's largely responsible for
its opioid-like effects, especially when
you get the dosage up to a level where
you start getting the mild sedation, the
analgesia, the pain relief. And keep in
mind, a lot of people are taking kratom
because they want pain relief. And when
that mu opioid receptor system is
activated, it indirectly activates a lot
of the reinforcement circuitry in the
brain that relates to dopamine and
serotonin. This is another area that
we'll go into in more depth in the
future, but there's been a lot of
controversy. People saying, "Oh, you
know, kratom doesn't trigger the
dopamine system, therefore, it's not
addictive." But that is simply not true.
It indirectly activates the
reinforcement circuitry that includes
both dopamine and serotonin, but its
primary effect is to hit this mu opioid
receptor system that exists in a bunch
of places in the brain, but mainly in
the brainstem and a structure called the
periaqueductal gray nucleus, which then
provides pain relief. It triggers a
number of different shifts in cognition.
It's what creates that mild euphoria,
etc., etc.
Now,
how can we be so confident that kratom
is acting so similarly to hydrocodone
and to morphine, albeit with lower
potency. And the reason is if you give
people a drug that blocks the mu opioid
receptor prior to them taking kratom,
they don't experience any of the classic
effects of taking kratom.
No euphoria, no analgesia, no sedation,
uh even at the low dosages, no mild
stimulant effect. So,
we really have to look at kratom as an
opioid. Okay? That's just the honest
truth. And if you're somebody who
doesn't like this message because you
like kratom, I'm not telling you that
you don't like kratom. I'm telling you
you likely like kratom because it's an
opioid. So again, if you go online and
you start asking questions about kratom,
again, you're going to see these two
camps. You're going to see the
kratom is terrible,
it's addictive, it's everything bad
camp. And then you're going to see the
other camp out there,
very vocal as well,
talking about how kratom helped them
avoid other things that are worse. And
you know, this is an argument that
frankly, I don't think we want to lean
on, right? The idea that substance A is
not as bad as substance B, and that
making substance A unavailable is just
going to send everyone running for
substance B,
you know,
that's a weak argument, frankly, right?
I heard this argument around cannabis.
And by the way, I'm I think pretty
balanced about cannabis. If you listen
to the episode I did on cannabis, I
think you'll agree that I believe that
cannabis has its therapeutic
applications. I also believe that young
people,
especially young males with a
predisposition to psychosis, should not
be taking high concentration THC
cannabis because the data tell us they
are already at risk of psychosis, and
they are at a much greater risk of
psychosis if they do. So, I think I'm
pretty balanced about the story on
cannabis.
But I often hear the argument, "Oh,
cannabis isn't as bad as alcohol, and
therefore cannabis is good."
That's simply not rational. What we
should be saying is whether or not it's
cannabis or alcohol or kratom or any
substance for that matter, what are the
potential benefits? What are the
potential risks? And
again, this is far too much that we can
go into in this AMA and we will go into
in a future full-length episode of the
Huberman Lab Podcast, but the other
thing to really keep in mind is the lack
of regulation over kratom supplements.
Now, as many of you know, I am a fan of
many, not all, but many supplements in
certain conditions. I always say
behaviors first, then nutrition, then if
and only if it's needed, rely on
supplementation. But supplementation is
a big category. But when we're talking
about supplements that are opioid
compounds, I start to get nervous
because of the high abuse potential and
the high addiction potential of opioids
and kratom is included in that category.
A couple of other key notes about
kratom.
While death directly from kratom is
fairly rare, it has happened.
Now, hydrocodone and morphine suppress
respiration. Actually, suppress
breathing by the way of a mechanism that
if you're a listener of the Huberman Lab
Podcast, you know about, which is the
so-called physiological sigh. Many of
you heard me talk about the
physiological sigh as something that you
do voluntarily, the double inhale
through the nose and then a long exhale
in order to rapidly reduce your level of
stress. As far as we know, that's the
fastest way to deliberately lower your
level of stress.
But the physiological sigh was
discovered in the 1930s as a spontaneous
pattern of breathing that occurs
involuntarily in sleep in order to
reinflate the lungs and offload carbon
dioxide and bring oxygen back into the
system on the subsequent breath. When I
interviewed Dr. Jack Feldman, who is a
professor at University of California,
Los Angeles and really the pioneer of
the modern neuroscience understanding of
respiration,
he talked about some studies in his
laboratory that were exploring why
people die when taking opioids.
This is a major issue associated with
the opioid crisis. And what he mentioned
was that the opioids bind to particular
receptors in the brainstem locations
that generate physiological sighs. So,
opioids, when taken as drugs, suppress
physiological sighing and do so during
sleep and lack of adequate respiration,
meaning people stop breathing during
sleep, is one of the primary reasons why
people die when they take opioids. Now,
kratom is not known to suppress
respiration when taken at low to
moderate dosages, but when combined with
any other opioids
and certainly when combined with
alcohol, it can suppress respiration.
And while the data on this are fairly
scant,
there is some evidence that
kratom-induced death is caused by
suppression of the respiration system.
So, again, death due to taking kratom at
the dosages that are recommended on most
commercial packaging
is fairly rare, although it has
happened. It's unclear if it happened
because it was taken in combination with
other compounds. That seems likely, but
we can't forget that a lot of people are
taking kratom at much higher dosages and
in fact progressively higher and higher
dosages
from these over-the-counter sources. And
with increased dosage, there is, yes, an
increased risk of respiratory failure.
So,
again, all of this points to the fact
that kratom is simply not a benign
substance. So, if we're going to be very
honest,
the addictive potential of kratom is
real.
It is exacerbated for some people
compared to others, but it is real. It's
very similarities to other more potent
forms of opioids are what make it
attractive for some people who are
trying to come off those more potent
form of opioids. But,
the goal, of course, is to completely
come off all opioids. And kratom itself
can be a bit of a trap. It can be a trap
in the sense that people who have never
taken other opioids can become addicted
to kratom itself. That is absolutely
clear. That can happen. It has happened
in a great number of people. It's also
clear that kratom can potentially be a
trap. Notice I said potentially because
if people are trying to come off other
more potent forms of opioids and then
they use kratom to do that and then
they're ratcheting up their dosage of
kratom such that they're now matching
the endogenous response to kratom in a
way that doesn't really distinguish from
the effects that they were getting from
morphine and hydrocodone, well, then
they're just using a different form of
morphine and hydrocodone. And I'm sure
that some of you are out there saying,
"That is ridiculous. You cannot compare
the effects of kratom to the effects of
hydrocodone." But, the potency is about
1/6 of hydrocodone and there are people
out there who are just increasing and
increasing both the
dosage and modifying the type of kratom
that they're taking so that they're
getting the kratom that has a
particularly high concentration of one
of the alkaloids that hits that mu
opioid receptor hardest. And in doing
so, sure, they're not getting the pure
hydrocodone effect, but they're getting
really close. So, my advice would be if
you haven't touched kratom, don't touch
it at all, ever. If you are taking
kratom, you need to take note of what we
just discussed. Thank you for joining
for the beginning of this Ask Me
Anything episode. To hear the full
episode and to hear future episodes of
these Ask Me Anything sessions, plus to
receive transcripts of them and
transcripts of the Huberman Lab Podcast
standard channel and premium tools not
released anywhere else, please go to
hubermanlab.com/premium.
Just to remind you why we launched the
Huberman Lab Podcast premium channel,
it's really twofold. First of all, it's
to raise support for the standard
Huberman Lab Podcast channel, which, of
course, will still be continued to be
released every Monday in full length. We
are not going to change the format or
anything about the standard Huberman Lab
Podcast, and to fund research. In
particular, research done on human
beings, so not animal models, but on
human beings, which I think we all agree
is a species that we are most interested
in and we are going to specifically fund
research that is aimed toward developing
further protocols for mental health,
physical health, and performance. And
those protocols will be distributed
through all channels, not just the
premium channel, but through all
channels, Huberman Lab podcast and other
media channels. So, the idea here is to
give you information to your burning
questions in depth and allow you the
opportunity to support the kind of
research that provides those kind of
answers in the first place. Now, an
especially exciting feature of the
premium channel is that the Tiny
Foundation has generously offered to do
a dollar-for-dollar match on all funds
raised for research through the premium
channel.
So, this is a terrific way that they're
going to amplify whatever funds come in
through the premium channel to further
support research for science and
science-related tools for mental health,
physical health, and performance. If
you'd like to sign up for the Huberman
Lab premium channel, again, there's a
cost of $10 per month or you can pay
$100 up front for the entire year. That
will give you access to all the AMAs.
You can ask questions and get answers to
your questions and you'll, of course,
get answers to all the questions that
other people ask as well. There will
also be some premium content such as
transcripts of the AMAs and various
transcripts and protocols of Huberman
Lab podcast episodes and not found
elsewhere. And again, you'll be
supporting research for mental health,
physical health, and performance. You
can sign up for the premium channel by
going to hubermanlab.com/premium.
Again, that's hubermanlab.com/premium.
And as always, thank you for your
interest in science.